Plasma exosomal miR-122 regulates the efficacy of metformin via AMPK in type 2 diabetes and hepatocellular carcinoma

Metformin is a drug that has been applied in clinical use for many years for the treatment of type 2 diabetes mellitus (T2DM). It achieves its function through multiple targets and modulation of multiple signaling pathways. To date, the mechanism of the action of metformin is still not fully underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hui, Hou, Mei, Wu, Zixin, Wang, Jing, Zhou, Man, Zhuang, Xiangjin, Xing, Jiayu, Tao, Qianqian, Huang, Long, Zhou, Fuhai, Zhang, Shengming, Feng, Qiyu, Hou, Yilin, Yu, Qinsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674877/
https://www.ncbi.nlm.nih.gov/pubmed/36411886
http://dx.doi.org/10.1016/j.heliyon.2022.e11503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674877/
https://www.ncbi.nlm.nih.gov/pubmed/36411886
http://dx.doi.org/10.1016/j.heliyon.2022.e11503

Ejemplares similares